澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

RHYTHM BIOSCIENCES LTD

0.120

+0.0109.09%

成交量：46.01萬

成交額：5.47萬

市值：3,912.82萬

市盈率：-8.44

高：0.120

開：0.110

低：0.110

收：0.110

52周最高：0.210

52周最低：0.047

股本：3.26億

流通股本：1.88億

量比：1.01

換手率：0.24%

股息：- -

股息率：- -

每股收益(TTM):-0.014

每股收益(LYR):-0.014

淨資產收益率：-501.54%

總資產收益率：-107.16%

市淨率：59.29

市盈率(LYR):-8.44

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

RHYTHM BIOSCIENCES LTD - 與皇家薩里國民保健基金信託的南方中心研究團隊達成合作

Rhythm Biosciences - 合作評估Colostat在英格蘭結腸癌篩查路徑中的適用性

Rhythm Biosciences宣佈Gavin Fox-Smith擔任董事長

RHYTHM Biosciences (ASX:RHY)連日暴漲：ColoSTAT試劑盒可有效檢測各階段結直腸癌

澳洲财经见闻

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/RHY.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RHY.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","market":"AU","secType":"STK","nameCN":"RHYTHM BIOSCIENCES LTD","latestPrice":0.12,"timestamp":1766466720000,"preClose":0.11,"halted":0,"volume":460148,"delay":0,"nameEN":"RHYTHM BIOSCIENCES LTD","floatShares":188306561,"shares":326068419,"eps":-0.014222,"marketStatus":"未開盤","change":0.01,"latestTime":"12-23 16:12:00 AEDT","open":0.11,"high":0.12,"low":0.11,"amount":54731,"amplitude":0.090909,"askPrice":0.125,"askSize":504923,"bidPrice":0.115,"bidSize":235014,"shortable":3,"etf":0,"ttmEps":-0.014222,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1766530800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.11,"openAndCloseTimeList":[[1766444400000,1766466000000]],"volumeRatio":1.006196,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","floatShares":188306561,"roa":"-107.16%","roe":"-501.54%","lyrEps":-0.014222,"volumeRatio":1.006196,"shares":326068419,"dividePrice":0,"high":0.12,"amplitude":0.090909,"preClose":0.11,"low":0.11,"week52Low":0.047,"pbRate":"59.29","psRate":"12.26","week52High":0.21,"institutionHeld":0,"latestPrice":0.12,"committee":-0.364773,"eps":-0.014222,"divideRate":0,"volume":460148,"delay":0,"ttmEps":-0.014222,"open":0.11,"prevYearClose":0.087,"prevWeekClose":0.097,"prevMonthClose":0.086,"prevQuarterClose":0.083,"fiveDayClose":0.085,"twentyDayClose":0.09,"sixtyDayClose":0.083,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RHY.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-07-27","symbol":"RHY.AU","type":"split","dateTimestamp":1595772000000,"forFactor":875,"toFactor":1000,"ratio":0.875}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RHY.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RHY.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1138402806","title":"RHYTHM BIOSCIENCES LTD - 與皇家薩里國民保健基金信託的南方中心研究團隊達成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1138402806","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138402806?lang=zh_tw&edition=fundamental","pubTime":"2025-12-10 05:58","pubTimestamp":1765317523,"startTime":"0","endTime":"0","summary":"RHYTHM BIOSCIENCES LTD - 与皇家萨里国民保健基金信托的南方中心研究团队达成合作","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"1125661818","title":"Rhythm Biosciences - 合作評估Colostat在英格蘭結腸癌篩查路徑中的適用性","url":"https://stock-news.laohu8.com/highlight/detail?id=1125661818","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125661818?lang=zh_tw&edition=fundamental","pubTime":"2025-12-10 05:56","pubTimestamp":1765317368,"startTime":"0","endTime":"0","summary":"Rhythm Biosciences - 合作评估Colostat在英格兰结肠癌筛查路径中的适用性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"1170673452","title":"Rhythm Biosciences宣佈Gavin Fox-Smith擔任董事長","url":"https://stock-news.laohu8.com/highlight/detail?id=1170673452","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170673452?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 00:37","pubTimestamp":1763570276,"startTime":"0","endTime":"0","summary":"11月5日 - Rhythm Biosciences Ltd公示：*GAVIN FOX-SMITH被任命为RHYTHM BIOSCIENCES的董事长*OTTO BUTTULA辞去董事长职务*更多公司信息：RHY.AX*","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2557550520","title":"RHYTHM Biosciences (ASX:RHY)連日暴漲：ColoSTAT試劑盒可有效檢測各階段結直腸癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2557550520","media":"澳洲财经见闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557550520?lang=zh_tw&edition=fundamental","pubTime":"2025-08-08 21:46","pubTimestamp":1754660815,"startTime":"0","endTime":"0","summary":"预测性癌症诊断技术公司RHYTHM Biosciences Ltd (ASX股票代码:RHY) 股价异动，周三再度暴涨4…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://afndaily.com/rhythm-biosciences-asxrhy%e8%bf%9e%e6%97%a5%e6%9a%b4%e6%b6%a8%ef%bc%9acolostat%e8%af%95%e5%89%82%e7%9b%92%e5%8f%af%e6%9c%89%e6%95%88%e6%a3%80%e6%b5%8b%e5%90%84%e9%98%b6%e6%ae%b5%e7%bb%93%e7%9b%b4/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","RHY.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RHY.AU\",params:#limit:6,delay:true,,,undefined,":[]}}